Metabolic evaluation of young women with congenital adrenal hyperplasia

Arq Bras Endocrinol Metabol. 2011 Nov;55(8):646-52. doi: 10.1590/s0004-27302011000800021.

Abstract

Objective: To evaluate insulin resistance and lipid profile in women with congenital adrenal hyperplasia (CAH) caused by classical 21-hydroxylase deficiency (21OHD), and their association with body mass index (BMI) and corticosteroid dosage.

Subjects and methods: We assessed BMI, waist circumference, current glucocorticoid dosage, glucose, insulin and lipid profile in eighteen young women (mean ± SD, 19.3 ± 3.0 years) with 21OHD CAH.

Results: BMI was normal in 12 patients, 5 of them were overweight, and 1 was obese. Waist circumference was high in 7 patients. Fasting insulin and HOMA-IR were elevated in seven and eight patients, respectively. Total cholesterol and triglycerides were high in only two patients, and HDL-cholesterol was low in four. Insulin resistance was not associated with BMI, waist circumference or glucocorticoid dose.

Conclusions: Young women with 21OHD CAH had infrequent dyslipidemia, but had a higher prevalence of insulin resistance and central obesity, that were independent of BMI or corticosteroid dosage.

MeSH terms

  • Adolescent
  • Adrenal Hyperplasia, Congenital / drug therapy
  • Adrenal Hyperplasia, Congenital / metabolism*
  • Blood Glucose / metabolism
  • Body Mass Index*
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Insulin / metabolism
  • Insulin Resistance / physiology*
  • Lipids / blood*
  • Obesity, Abdominal / diagnosis
  • Statistics, Nonparametric
  • Waist Circumference / physiology
  • Young Adult

Substances

  • Blood Glucose
  • Glucocorticoids
  • Insulin
  • Lipids

Supplementary concepts

  • Congenital adrenal hyperplasia due to 21 hydroxylase deficiency